研究目的
Evaluating the significance of adding an early static pelvic image to the 68Ga-PSMA-I&T PET/CT imaging protocol for detecting pelvic lesions in prostate cancer patients with suspected recurrence after definitive therapy.
研究成果
Adding an early static pelvic image to the 68Ga-PSMA-I&T PET/CT protocol may enhance the detection of malignant pelvic lesions that show rapid clearance and are at risk of being obscured by urinary activity in late images. Although no major discordance was found between early and late images, the early image could improve efficacy in specific cases, such as lesions that disappear in late scans. Further studies with larger cohorts are needed to confirm these findings.
研究不足
The study is retrospective with a small sample size (35 patients), limiting generalizability. Lack of histological confirmation for some lesions, and potential masking by urinary activity in late images. The use of 68Ga-PSMA-I&T may have different kinetics compared to other ligands like PSMA-11.
1:Experimental Design and Method Selection:
A retrospective study enrolling 35 prostate cancer patients referred for 68Ga-PSMA-I&T PET/CT imaging for restaging due to suspicion of relapse after definitive therapy. The study involved obtaining an early static pelvic image within 300 seconds post-injection and a whole-body PET/CT scan at 60 minutes post-injection, with comparison of lesions detected and SUVmax values between early and late images.
2:Sample Selection and Data Sources:
35 patients with prostate cancer, selected based on referral for restaging imaging, with data collected from August to December
3:List of Experimental Equipment and Materials:
20 PET/CT scanner (Siemens Biograph 6), radiotracer 68Ga-PSMA-I&T synthesized using Scintomics GRP module and 68Ge/68Ga generator from iThemba Labs, DOTAGA-PSMA from Scintomics GRP.
4:Experimental Procedures and Operational Workflow:
Patients received a weight-based injection of 68Ga-PSMA-I&T (2 MBq/kg, range 70-180 MBq). Early pelvic image acquired within 300 s post-injection, followed by whole-body PET/CT at 60 min with 3 min emission time per bed position. Low-dose CT for attenuation correction performed before emission scans.
5:Data Analysis Methods:
Images interpreted by two nuclear medicine specialists. SUVmax values measured for lesions and reference tissues. Statistical analysis using IBM SPSS Statistics 22, with non-parametric tests (Mann-Whitney U test, Wilcoxon signed-rank test) and Spearman correlation, significance set at p < 0.05.
独家科研数据包,助您复现前沿成果,加速创新突破
获取完整内容